/ Daily World News: Gilead Phase III trial of remdesivir for COVID-19 shows 65 percent are 'more likely' to improve by day 11 - Daily World News

Featured Posts

http://go.oclaserver.com/afu.php?zoneid=1713724

Breaking News

Home / FOX NEWS / Daily World News: Gilead Phase III trial of remdesivir for COVID-19 shows 65 percent are 'more likely' to improve by day 11

Daily World News: Gilead Phase III trial of remdesivir for COVID-19 shows 65 percent are 'more likely' to improve by day 11

June 01, 2020

Gilead Phase III trial of remdesivir for COVID-19 shows 65 percent are 'more likely' to improve by day 11



Gilead Sciences said on Monday that remdesivir, the experimental drug being tested for COVID-19, showed that 65 percent of moderately ill patients had improvement after 11 days.

via FOX NEWS https://ift.tt/2MmAjbm

No comments

Subscribe to: Post Comments ( Atom )